Table 5.

Hypothetical maximal flare occurrence for each disease state.

Time HorizonDisease StateNo. Flares, Median (IQR)P*
No. flares over 6 monthsRemission0 (0–0)< 0.001
LDA1 (0–2)
PASS0 (0–1)
No. flares over 12 monthsRemission0 (0–0)< 0.001
LDA1 (0–2)
PASS0 (0–2)
  • * From related samples Friedman 2-way ANOVA by ranks (all pairwise comparisons were also statistically significant). LDA: low disease activity; PASS: patient acceptable symptom state.